# Opticyte, Inc. — Form D

Opticyte, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-12. The offering totals $2.3M, of which $72K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-10-12
- Form: D
- Accession: 0001718984-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $72K
- Remaining: $2.2M
- Investors: 2
- Date of first sale: 2017-09-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-296546

## Issuer

- Name: Opticyte, Inc.
- CIK: 0001718984
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 4000 MASON ROAD, SUITE 300, SEATTLE, WA, 98195
- Phone: 206-775-5525

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Lorilee Arakaki | Director | Seattle, WA |
| Robert Masterson | Director | Seattle, WA |
| Kenneth Schenkman | Director | Seattle, WA |
| Lorilee Arakaki | Executive Officer | Seattle, WA |
| Robert Masterson | Executive Officer | Seattle, WA |
| Kenneth Schenkman | Executive Officer | Seattle, WA |
| Lorilee Arakaki | Promoter | Seattle, WA |
| Robert Masterson | Promoter | Seattle, WA |
| Kenneth Schenkman | Promoter | Seattle, WA |

## More

- [CIK 1718984 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1718984&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001718984-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.